IDEXX Laboratories, Inc. (IDXX) News
Filter IDXX News Items
IDXX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
IDXX News Highlights
- 500 - Internal server error
- Over the past 29 days, IDXX's stories per day has been in a clear downtrend, falling by about 0.46 per day.
- The most mentioned tickers in articles about IDXX are HCA, CAG and ESP.
Latest IDXX News From Around the Web
Below are the latest news stories about Idexx Laboratories Inc that investors may wish to consider to help them evaluate IDXX as an investment opportunity.
Why IDEXX Laboratories (IDXX) Might Surprise This Earnings SeasonIDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. |
Should JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) Be on Your Investing Radar?Style Box ETF report for JPME |
Robust Valuation Leaves Neogen Little Room For Error After Mixed Resultsdusanpetkovic/iStock via Getty Images Neogen (NEOG) has never traded in line with normal valuation metrics, and it may well never do so – or at least not over a reasonable investment horizon. The reality is that there’s scarcity value in the growth markets of food safety and animal safety, and... |
What's in Store for IDEXX Laboratories (IDXX) in Q2 Earnings?IDEXX's (IDXX) fiscal second-quarter top line is expected to have benefited from strength in CAG and LPD businesses. |
IDEXX Laboratories: This Growth Name Is On FireMarko Geber/DigitalVision via Getty ImagesFast-growers with industry-leading positions have a place in most portfolios. These may be the type of investments that one can set in a portfolio and leave there for many years, until they need to be cashed out. In this article, I’m focused on IDEXX Laboratories (IDXX),... |
Animal Health Diagnostics Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: IDEXX Laboratories (US), Abaxis (US), Thermo Fisher Scientific (US), Neogen (US),The documented report on Global Animal Health Diagnostics Market by Reports Globe aims to offer an organized and methodical strategy for important aspects that have affected the market in recent years and future market opportunities that companies can trust. It gives readers clear market research for better judgment and better decision making on whether or [] |
Animal Health Diagnostics Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:IDEXX Laboratories (US), Abaxis (US), Thermo Fisher Scientific (US), Neogen (US), HeskThis report studies the Animal Health Diagnostics Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Animal Health Diagnostics market segmented by company, [] |
Global Food Additives Testing Market 2021 With Pre & Post COVID-19 Impact Analysis | Top Key Players | Bureau Veritas Sa, IFP Institut Für Produktqualit t Gmbh, Idexx Laboratories Inc, Aegis Food Testing Laboratories IncMarket Research Store has released its latest study on the Food Additives Testing Market, which calculates market growth trends using historical data and assesses future prospects based on thorough research. The Food Additives Testing analysis covers market segmentation, growth, trends, and forecasting for the years 2021-2026. Every minute detail of the Food Additives Testing Market is [] |
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
3 Surprising Stocks That Have Crushed the Market so Far This YearShares of HCA Healthcare (NYSE: HCA) have skyrocketed more than 50% so far in 2021. HCA CEO Sam Hazen said in the company's recent second-quarter earnings call that HCA "experienced a strong rebound in demand for our services," thanks to a lower impact from the pandemic. Hazen noted that COVID-19 admissions in Q2 were only 3% of HCA's total admissions, compared to 10% in Q1. |